137 related articles for article (PubMed ID: 1545568)
1. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
Gronthos S; To LB; Haylock DN; Juttner CA
Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
[TBL] [Abstract][Full Text] [Related]
3. The interaction of 2-chlorodeoxyadenosine (2-CDA) and interferon alpha (IFN-alpha) on normal and myeloid leukemia hematopoiesis in vitro.
Robak T; Korycka A; Góra-Tybor J
Leuk Res; 1994 Apr; 18(4):275-81. PubMed ID: 7909573
[TBL] [Abstract][Full Text] [Related]
4. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.
Marley SB; Davidson RJ; Goldman JM; Gordon MY
Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234
[TBL] [Abstract][Full Text] [Related]
5. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
Robak T; Korycka A
Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
[TBL] [Abstract][Full Text] [Related]
6. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response.
Geissler D; Gastl G; Aulitzky W; Tilg H; Gaggl S; Konwalinka G; Huber C
Leuk Res; 1990; 14(7):629-36. PubMed ID: 2388474
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
[TBL] [Abstract][Full Text] [Related]
8. The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint.
Dowding C; Guo AP; Maisin D; Gordon MY; Goldman JM
Br J Haematol; 1991 Feb; 77(2):165-71. PubMed ID: 2004017
[TBL] [Abstract][Full Text] [Related]
9. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia.
Wandl UB; Niederle N; Kranzhoff M; Seeber S
Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016
[TBL] [Abstract][Full Text] [Related]
10. Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha.
Nirsimloo N; Gordon MY
Leuk Res; 1995 May; 19(5):319-23. PubMed ID: 7769832
[TBL] [Abstract][Full Text] [Related]
11. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
Sagayadan GE; Wiernik PH; Sun N; Ahearn G; Thompson D; Hallam SJ; Hu XP; Dutcher JP; Gallagher RE
Leuk Res; 1994 Oct; 18(10):741-8. PubMed ID: 7934131
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo.
Paquette RL; Hsu N; Said J; Mohammed M; Rao NP; Shih G; Schiller G; Sawyers C; Glaspy JA
Leukemia; 2002 Aug; 16(8):1484-9. PubMed ID: 12145689
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.
Osterholz J; Dowding C; Guo AP; Siczkowski M; Goldman JM
Exp Hematol; 1991 Jun; 19(5):326-31. PubMed ID: 2026184
[TBL] [Abstract][Full Text] [Related]
14. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro.
Mahon FX; Chahine H; Barbot C; Pigeonnier V; Jazwiec B; Reiffers J; Ripoche J
Leukemia; 1997 May; 11(5):667-73. PubMed ID: 9180290
[TBL] [Abstract][Full Text] [Related]
15. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
16. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
[TBL] [Abstract][Full Text] [Related]
17. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
Korycka A; Robak T
Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
[TBL] [Abstract][Full Text] [Related]
18. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
Gordon MY; Marley SB; Lewis JL; Davidson RJ; Nguyen DX; Grand FH; Amos TA; Goldman JM
J Clin Invest; 1998 Aug; 102(4):710-5. PubMed ID: 9710439
[TBL] [Abstract][Full Text] [Related]
19. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
Estrov Z; Markowitz AB; Kurzrock R; Wetzler M; Kantarjian HM; Ferrajoli A; Gutterman JU; Talpaz M
Leukemia; 1993 Feb; 7(2):214-20. PubMed ID: 8426475
[TBL] [Abstract][Full Text] [Related]
20. Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +- alpha-interferon.
Ferrero D; Foli C; Giaretta F; Argentino C; Rus C; Pileri A
Leukemia; 2001 Mar; 15(3):422-9. PubMed ID: 11237066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
